Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update
MARSEILLE, France–(BUSINESS WIRE)–$Innate #Biotech–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announces that the Company will hold a conference call on Wednesday, May 13, 2026 at 1:30 p.m. CEST / 7:30 a.m. EDT, to provide an update on business progress for the first quarter of 2026. Participants during … [Read more…]
